Sentiment Trading

Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company pioneering gene therapy for rare diseases, making significant strides in the biotechnology sector and offering new hope to patients and families affected by these conditions.

Abeona Therapeutics Inc. has received FDA approval for its groundbreaking gene therapy, ZEVASKYN, marking a historic milestone in the treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB).